OXYGENTA PHARMA Standalone September 2024 Net Sales at Rs 14.01 crore, up 7.11% Y-o-Y
November 25, 2024 / 11:10 IST
Reported Standalone quarterly numbers for OXYGENTA PHARMACEUTICAL are:Net Sales at Rs 14.01 crore in September 2024 up 7.11% from Rs. 13.08 crore in September 2023.
Quarterly Net Loss at Rs. 2.85 crore in September 2024 up 9.69% from Rs. 3.16 crore in September 2023.
EBITDA stands negative at Rs. 1.42 crore in September 2024 up 28.28% from Rs. 1.98 crore in September 2023.
| OXYGENTA PHARMA shares closed at 73.10 on November 22, 2024 (BSE) and has given 99.13% returns over the last 6 months and 125.69% over the last 12 months. |
| OXYGENTA PHARMACEUTICAL | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'24 | Jun'24 | Sep'23 | | Net Sales/Income from operations | 14.01 | 12.62 | 13.08 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 14.01 | 12.62 | 13.08 | | EXPENDITURE | | Consumption of Raw Materials | 7.94 | 10.66 | 11.68 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 2.90 | -0.66 | -0.14 | | Power & Fuel | -- | -- | -- | | Employees Cost | 1.40 | 1.48 | 0.33 | | Depreciation | 0.66 | 0.65 | 0.83 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.94 | 2.92 | 3.19 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -2.83 | -2.43 | -2.81 | | Other Income | 0.75 | 0.02 | 0.00 | | P/L Before Int., Excpt. Items & Tax | -2.08 | -2.41 | -2.81 | | Interest | 0.69 | 0.41 | 0.34 | | P/L Before Exceptional Items & Tax | -2.77 | -2.82 | -3.15 | | Exceptional Items | -- | -- | -0.03 | | P/L Before Tax | -2.77 | -2.82 | -3.18 | | Tax | 0.08 | -1.45 | -0.02 | | P/L After Tax from Ordinary Activities | -2.85 | -1.36 | -3.16 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -2.85 | -1.36 | -3.16 | | Equity Share Capital | 35.48 | 35.48 | 33.48 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.81 | -0.39 | -0.87 | | Diluted EPS | -0.78 | -0.37 | -0.76 | | EPS After Extra Ordinary | | Basic EPS | -0.81 | -0.39 | -0.87 | | Diluted EPS | -0.78 | -0.37 | -0.76 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
